Pharmacophore model, docking, QSAR, and molecular dynamics simulation studies of substituted cyclic imides and herbal medicines as COX-2 inhibitors

por Moussa, Nathalie, Hassan, Ahmad, Gharaghani, Sajjad
Publicado 2021

Structural systems pharmacology: A framework for integrating metabolic network and structure-based virtual screening for drug discovery against bacteria

por Nazarshodeh, Elmira, Marashi, Sayed-Amir, Gharaghani, Sajjad
Publicado 2021

DRaW: prediction of COVID-19 antivirals by deep learning—an objection on using matrix factorization

por Hashemi, S. Morteza, Zabihian, Arash, Hooshmand, Mohsen, Gharaghani, Sajjad
Publicado 2023

In silico studies of anti-oxidative and hot temperament-based phytochemicals as natural inhibitors of SARS-CoV-2 M(pro)

por Naderi Beni, Ramin, Elyasi-Ebli, Parisa, Gharaghani, Sajjad, Seyedarabi, Arefeh
Publicado 2023

Rational approaches to discover SARS-CoV-2/ACE2 interaction inhibitors: Pharmacophore-based virtual screening, molecular docking, molecular dynamics and binding free energy studies

por Yazdani, Mohsen, Jafari, Ameneh, Mahdian, Soodeh, Namazi, Mohsen, Gharaghani, Sajjad
Publicado 2023

Sequential and Mixed Genetic Algorithm and Learning Automata (SGALA, MGALA) for Feature Selection in QSAR

por MotieGhader, Habib, Gharaghani, Sajjad, Masoudi-Sobhanzadeh, Yosef, Masoudi-Nejad, Ali
Publicado 2017

AutoDTI++: deep unsupervised learning for DTI prediction by autoencoders

por Sajadi, Seyedeh Zahra, Zare Chahooki, Mohammad Ali, Gharaghani, Sajjad, Abbasi, Karim
Publicado 2021

Moonlighting protein prediction using physico-chemical and evolutional properties via machine learning methods

por Shirafkan, Farshid, Gharaghani, Sajjad, Rahimian, Karim, Sajedi, Reza Hasan, Zahiri, Javad
Publicado 2021

Correction to: Moonlighting protein prediction using physico‑chemical and evolutional properties via machine learning methods

por Shirafkan, Farshid, Gharaghani, Sajjad, Rahimian, Karim, Sajedi, Reza Hasan, Zahiri, Javad
Publicado 2021

Exploring the role of non-coding RNAs as potential candidate biomarkers in the cross-talk between diabetes mellitus and Alzheimer’s disease

por Ghiam, Shokoofeh, Eslahchi, Changiz, Shahpasand, Koorosh, Habibi-Rezaei, Mehran, Gharaghani, Sajjad
Publicado 2022

Identification of repurposed drugs targeting significant long non-coding RNAs in the cross-talk between diabetes mellitus and Alzheimer’s disease

por Ghiam, Shokoofeh, Eslahchi, Changiz, Shahpasand, Koorosh, Habibi-Rezaei, Mehran, Gharaghani, Sajjad
Publicado 2022

Inhibition of GSK_3β by Iridoid Glycosides of Snowberry (Symphoricarpos albus) Effective in the Treatment of Alzheimer’s Disease Using Computational Drug Design Methods

por Eskandarzadeh, Marzieh, Kordestani-Moghadam, Parastou, Pourmand, Saeed, Khalili Fard, Javad, Almassian, Bijan, Gharaghani, Sajjad
Publicado 2021

DEDTI versus IEDTI: efficient and predictive models of drug-target interactions

por Zabihian, Arash, Sayyad, Faeze Zakaryapour, Hashemi, Seyyed Morteza, Shami Tanha, Reza, Hooshmand, Mohsen, Gharaghani, Sajjad
Publicado 2023

Melatonin Therapy Modulates Cerebral Metabolism and Enhances Remyelination by Increasing PDK4 in a Mouse Model of Multiple Sclerosis

por Ghareghani, Majid, Scavo, Linda, Jand, Yahya, Farhadi, Naser, Sadeghi, Hossein, Ghanbari, Amir, Mondello, Stefania, Arnoult, Damien, Gharaghani, Sajjad, Zibara, Kazem
Publicado 2019